The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients

被引：0
|
作者：
Anne Flint
Christoph Kapitza
Charlotte Hindsberger
Milan Zdravkovic
机构：
[1] Novo Nordisk A/S,
[2] Novo Nordisk A/S,undefined
[3] PROFIL Institut für Stoffwechselforschung GmbH,undefined
来源：
Advances in Therapy | 2011年 / 28卷
关键词：
exenatide; gastric emptying; incretin; insulin; type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：213 / 226
页数：13
相关论文
共 50 条
  • [31] Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes
    Trujillo, Jennifer M.
    Goldman, Jennifer
    PHARMACOTHERAPY, 2017, 37 (08): : 927 - 943
  • [32] Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation
    Punjabi, Mukesh
    Arnold, Myrtha
    Geary, Nori
    Langhans, Wolfgang
    Pacheco-Lopez, Gustavo
    PHYSIOLOGY & BEHAVIOR, 2011, 105 (01) : 71 - 76
  • [33] THE COLON AS A SOURCE FOR GLUCAGON-LIKE PEPTIDE-1 (GLP-1)
    HOLST, JJ
    OLESEN, KM
    GUDMANDHOYER, E
    DEACON, CF
    HANSEN, CP
    JOHNSEN, AH
    MIHOLIC, J
    NAUCK, M
    QUALMANN, C
    DIABETOLOGIA, 1995, 38 : A170 - A170
  • [34] STRUCTURE OF HUMAN GLP-1 (GLUCAGON-LIKE PEPTIDE-1) CONTAINING PEPTIDES
    ORSKOV, C
    KOFOD, H
    RABENHOJ, L
    WETTERGREN, A
    HOLST, JJ
    REGULATORY PEPTIDES, 1992, 40 (02) : 223 - 223
  • [35] STRUCTURE OF HUMAN GLP-1(GLUCAGON-LIKE PEPTIDE-1) CONTAINING PEPTIDES
    ORSKOV, C
    KOFOD, H
    RABENHOJ, L
    WETTERGREN, A
    HOLST, JJ
    DIABETOLOGIA, 1992, 35 : A109 - A109
  • [36] Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
    Nauck, M. A.
    Vardarli, I.
    Deacon, C. F.
    Holst, J. J.
    Meier, J. J.
    DIABETOLOGIA, 2011, 54 (01) : 10 - 18
  • [37] Modern possibilities of pharmacotherapy of type 2 diabetes using analogues of glucagon-like peptide-1 (GLP-1)
    Shestakova, M., V
    Vikulova, O. K.
    DIABETES MELLITUS, 2007, 10 (01): : 9 - 15
  • [38] CJC-1131 -: Agent for type 2 diabetes glucagon-like peptide-1 (GLP-1) analogue
    Davies, SJ
    Martín, L
    Castañer, RM
    DRUGS OF THE FUTURE, 2005, 30 (06) : 553 - 557
  • [39] The once-daily human GLP-1 analogue liraglutide decreases postprandial hunger and energy intake
    Flint, Anne
    Kapitza, Christoph
    Hinds-Berger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A165 - A165
  • [40] Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
    M. A. Nauck
    I. Vardarli
    C. F. Deacon
    J. J. Holst
    J. J. Meier
    Diabetologia, 2011, 54 : 10 - 18
12345